Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2021

MissionIRNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Issues Update on Underwritten Public Offering of American Depositary Shares

Posted on November 11, 2021 by MissionIR

AnPac Bio (NASDAQ: ANPC) today issued a correction to its press release dated Nov. 9, 2021, regarding the pricing of its underwritten public offering of American Depositary Shares (“ADSs”). According to the update, the original release referenced the dollar size of … Continue reading →

Posted in AnPac Bio-Medical Science Co. Ltd. ANPC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – FingerMotion Inc.’s (FNGR) Q2 Results Represent ‘Transition to Greater Profitability’

Posted on November 11, 2021 by MissionIR

FingerMotion (OTCQX: FNGR), a communications and big data technology platform builder, recently released its Q2 results. “The China-focused enterprise reported quarterly revenue of $5.39 million, which included a 25% year-over-year quarterly growth in its short and multimedia messaging (‘SMS’ and … Continue reading →

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Second US Patent for Innovative UST(TM) Platform, NanoGap(TM) Valve

Posted on November 11, 2021 by MissionIR

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialized services to the worldwide life sciences and other key industries, today announced the award of its second U.S. patent for … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Announces Strategic Coffee Business Acquisitions

Posted on November 11, 2021 by MissionIR

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its acquisition of a majority equity interests in each of Eh Coffee Corp. and Portfolio Coffee Inc. from their respective shareholders for a purchase price comprised of common shares of PlantX … Continue reading →

Posted in MissionIRNewsBreaks, PlantX Life Inc. PLTXF | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at Jefferies London Healthcare Conference

Posted on November 11, 2021 by MissionIR

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that its CEO Doug Drysdale will present at the Jefferies London Healthcare Conference. The event is slated to be held in a virtual … Continue reading →

Posted in Cybin Inc. CYBN, MissionIRNewsBreaks | Leave a comment

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Teaches Benefits of Plant-based Living Through Expanding Profile of Market, Media Outlets

Posted on November 11, 2021 by MissionIR

Plant community brand builder PlantX Life Inc. is a growing e-commerce hub with over 5,000 products reflecting its focus on plant-based foods, greenery, textiles, and other items The company recently opened a brick-and-mortar store in the San Diego, Calif., area, … Continue reading →

Posted in PlantX Life Inc. PLTXF | Leave a comment

InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid

Posted on November 10, 2021 by MissionIR

InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabinoid that may inhibit or slow the progression of neurodegenerative disease and potentially enhance the neuronal function With neurogenerative diseases affecting millions worldwide and the cost of treating … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Results, Business Updates for Q1 2022

Posted on November 10, 2021 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has reported its financial numbers and corporate update for first-quarter 2022, the period ended Sept. 30, 2021. Highlights of the report included the company’s completion … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands 2022 R&D Programs to Evaluate Potential Treatment Options for Alzheimer’s and Diabetes

Posted on November 10, 2021 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its plans for several new and ongoing DehydraTECH(TM)-applied R&D programs for 2022. According to the update, the studies mentioned in the announcement represent only a fraction … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

Tingo Inc. (IWBB) Seeks to List Shares on NYSE; Seeks to Capitalize on Strong Investor Demand for Peer Companies

Posted on November 10, 2021 by MissionIR

Tingo Inc has recently submitted its application to list its shares on the New York Stock Exchange The company has sought to increase overall liquidity in their shares and drive shareholder returns Peer companies operating within Tingo Inc’s business verticals … Continue reading →

Posted in Tingo Inc. IWBB | Leave a comment